Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01617993 · ClinicalTrials.gov registry record

Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting

A clinical trial of Infertility, sponsored by Progyny.

Completed
Registry status
31
Enrollment target
3
Study locations

NCT01617993: Completed study of Infertility, sponsored by Progyny.

NCT01617993 is a study of Infertility that has completed, run by Progyny. The registered enrollment target is 31 participants, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01617993, a study of Infertility, has completed, sponsored by Progyny.

COMPLETED
Registry status
31 participants
Enrollment target
3
Study locations

Study Summary

User questionnaire of Eeva System usability and reports of device malfunctions.

Conditions Studied

Study Locations (3)

California

  • Pacific Fertility Center - San Francisco
  • Fertility Physicians of Northern California - San Jose
  • Reproductive Science Center - San Ramon

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2012-06
Est. Completion 2013-02
Progyny

4 total trials

What the finished NCT01617993 record still lists

NCT01617993 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 7,589-participant average among 74 other Infertility trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT01617993 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01617993 about?

NCT01617993 is a clinical study titled "Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting". User questionnaire of Eeva System usability and reports of device malfunctions.

What is the current status of trial NCT01617993?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2012-06. Estimated completion is 2013-02.

What conditions does trial NCT01617993 study?

This clinical trial studies the following conditions: Infertility.

Who is sponsoring clinical trial NCT01617993?

This trial is sponsored by Progyny, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01617993 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01617993's enrollment target sits among peer trials

31 70th of 74 higher than 5 of 74 other Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01617993, the US trial registry maintained by the National Library of Medicine. NCT01617993 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.